For 24 years, DDP has been the world's largest drug delivery meeting place to accelerate drugs to market and lengthen lifecycles for long term profitability by finding new partners, new drug delivery technologies, and new formulation development strategies. Year after year this event brings together top scientists and business development leaders from Biotech, Pharma, Generics, Specialty Pharma and Drug Delivery companies to share, discuss, and collaborate. If you work in drug delivery, commercialization/licensing, med device, formulation, biologics, biosimilars, and similar areas, you can't miss this event! DDP Is The Perfect Blend of Science and Business DevelopmentWhether you need to source new partnerships and qualify new deals, or you prefer to delve into the scientific aspects of new drug delivery technologies and innovation, DDP offers it all. Alongside 20+ hours of one-on-one partnering meetings, there will be numerous drug delivery tracks, scientific workshops, and more. Highly acclaimed industry experts from Boehringer Ingelheim, MedImmune, Merck, Catalent, IDEO, and more share big ideas, critical concepts, and thought leadership on the next leap forward in• Patient-centric drug deliveries and technologies• Disruptive Innovation• Healthcare and Policy• The Future of Drug Delivery• Med Devices• Biosimilar• Biologics• 3D Printing• Combination Products• Oral therapies• New Product Launches and Start-Up Technology• Big Data• Drug Delivery Evolution• Alliance management and negotiation This is the only drug delivery event with partneringONE® partneringONE® is a powerful networking tool that allows you to meet the right people and achieve your goals through one-on-one meetings, all within the palm of your hand. In just three days at DDP, you can have more one-on-one meetings with potential/existing partners than perhaps you will the rest of the year and partnering early helps to accelerate a product's speed to market. URLs:Tickets: https://go.evvnt.com/509655-2?pid=5569Website: https://go.evvnt.com/509655-3?pid=5569Brochure: https://go.evvnt.com/509655-4?pid=5569Website: https://go.evvnt.com/509655-5?pid=5569Website: https://go.evvnt.com/509655-6?pid=5569Website: https://go.evvnt.com/509655-7?pid=5569Website: https://go.evvnt.com/509655-8?pid=5569 On Monday March 30, 2020 at 8:00 am (ends Wednesday April 01, 2020 at 5:00 pm) Venue details:Hyatt Regency Orlando, 9801 International Drive, Orlando, 32819, United States Price:Pharma 3-Day All-Access Pass (includes Pre-Conference Workshops) - Early Bird Rate Expires November 22, 2019: USD 1795.0,Pharma 2-Day Conference Pass - Early Bird Rate Expires November 22, 2019: USD 1195.0,Vendor 3-Day All-Access Pass (includes Pre-Conference Workshops) - Early Bird Rate Expires November 22, 2019: USD 2495.0,Vendor 2-Day Main Conference Pass - Early Bird Rate Expires November 22, 2019: USD 1895.0,Academic/Government 3-Day All-Access Pass (includes Pre-Conference Workshops) - Early Bird Rate Expires November 22, 2019: USD 995.0,Academic/Government 2-Day Main Conference Pass - Early Bird Rate Expires November 22, 2019: USD 695.0 Speakers: John Chiminski, Chair and CEO, Catalent, Inc., Jesse Fourt, Design Director, IDEO, Ronald Smith, Ph.D., Scientific AVP, Pharmaceutical Sciences, Merck Research Laboratories, Prat Ganapathy, Design Director, IDEO, Vlad Coric, MD, CEO and Director, biohaven pharmaceuticals, Uri Baruch, Head of Drug Delivery, Cambridge Design Partnerships, Bastiaan deLeeuw, Head of Business Development, Drug Delivery, Cambridge Design Partnership, Rakesh Dixit, Ph.D., DABT, President & CEO, Bionavigen, Former VP, R&D, MedImmune, Keith Horspool, Ph.D., VP Pharmaceutics, Boehringer Ingelheim, Joshua Horvath, Ph.D., Associate Director, Device Development, Genentech, Ralph Lipp, Ph.D., VP and Chief Scientific Officer, Noven Pharmaceuticals, Inc., Bob Nissen, President, Nissen Consulting, Russell Pott, Ph.D., Founder of Russ Potts Consulting, LLC, Mathias Romacker, Senior Director, Device Strategy, Pfizer, Srini Sridharan, Ph.D., Group Director, Materials Science & Engineering, Bristol-Myers Squibb, Cornell Stamoran, Ph.D., VP of Corporate Strategy, Catalent Pharma Solutions, Ian Tzeng, Managing Director and Partner, L.E.K. Consulting, Kerstin Walke, Ph.D., Head Pharmaceutical Development Biologicals, Boehringer Ingelheim, Courtney Zeni, Ph.D., Director, Medical Affairs, Product Development, Noven Pharmaceuticals, Inc.